Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine Prophylaxis for Health Care Workers at Risk for COVID
NCT04349371Phase 2Terminated
- Sponsor
- Columbia University
- Start
- Apr 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chloroquine in coronavirus disease 2019 (COVID-19), sponsored by Columbia University. Started Apr 2020; status: terminated.
02
Drugs
chloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04349371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04349371.